Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000596046 | SCV000707724 | likely benign | not specified | 2017-04-25 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001584406 | SCV001812509 | likely benign | not provided | 2020-12-22 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002448836 | SCV002733722 | likely benign | Inborn genetic diseases | 2018-01-30 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV002491218 | SCV002803400 | likely benign | Rubinstein-Taybi syndrome due to CREBBP mutations; Menke-Hennekam syndrome 1 | 2021-11-04 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002532587 | SCV003500033 | benign | Rubinstein-Taybi syndrome | 2024-10-24 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001584406 | SCV004140986 | likely benign | not provided | 2024-09-01 | criteria provided, single submitter | clinical testing | CREBBP: BP4, BP7, BS1 |